当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析

皓元医药

(688131)

  

流通市值:28.65亿  总市值:49.82亿
流通股本:8648.52万   总股本:1.50亿

皓元医药(688131)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.17亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益256332.06万元,未分配利润66042.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产432144.27万元,负债175812.22万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入504,874,103.591,880,046,769.141,376,113,868.75880,918,116.49
营业总成本465,236,626.831,672,706,963.811,187,610,757.49739,063,197.83
营业利润16,593,800.36128,328,584.25133,796,677.72111,364,575.34
利润总额16,700,129.51128,192,543.96132,797,955.07110,071,289.61
净利润16,536,169.84126,307,603.99116,758,100.5993,874,503.55
其他综合收益347,032.14827,004.882,701,650.756,511,856.68
综合收益总额16,883,201.98127,134,608.87119,459,751.34100,386,360.23
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,242,692,568.832,188,265,705.872,146,861,070.212,014,080,223.16
非流动资产合计2,078,750,166.162,003,942,224.381,973,341,400.111,962,168,666.93
资产总计4,321,442,734.994,192,207,930.254,120,202,470.323,976,248,890.09
流动负债合计1,211,266,462.661,163,812,417.731,110,759,095.291,018,736,644.71
非流动负债合计546,855,693.07502,117,458.82532,126,189.09518,278,212.36
负债合计1,758,122,155.731,665,929,876.551,642,885,284.381,537,014,857.07
归属于母公司股东权益合计2,543,858,967.162,509,078,803.362,466,673,119.022,428,164,768.51
股东权益合计2,563,320,579.262,526,278,053.72,477,317,185.942,439,234,033.02
负债和股东权益合计4,321,442,734.994,192,207,930.254,120,202,470.323,976,248,890.09
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计474,799,584.52,018,632,068.171,313,563,510.84883,010,668.31
经营活动现金流出小计446,474,098.492,082,238,246.641,507,462,298.621,078,024,078.23
经营活动产生的现金流量净额28,325,486.01-63,606,178.47-193,898,787.78-195,013,409.92
投资活动现金流入小计949,772.2929,549,566.38765,062,211.95643,084,981.93
投资活动现金流出小计120,462,037.341,258,060,525.491,059,166,343.78883,728,580.12
投资活动产生的现金流量净额-119,512,265.14-328,510,959.11-294,104,131.83-240,643,598.19
筹资活动现金流入小计165,645,972.06815,321,980.1595,246,241.58409,818,755.68
筹资活动现金流出小计105,667,376.89406,113,351.25253,176,153.92171,344,628.62
筹资活动产生的现金流量净额59,978,595.17409,208,628.85342,070,087.66238,474,127.06
汇率变动对现金及现金等价物的影响-425,949.693,110,971.276,707,4088,722,091.89
现金及现金等价物净增加额-31,634,133.6520,202,462.54-139,225,423.95-188,460,789.16
期末现金及现金等价物余额443,831,829.96475,465,963.61316,038,169.04266,802,711.91
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
平安证券叶寅,倪亦道0.931.412.092024-04-25
中信证券陈竹,韩世通0.801.101.562024-02-28
中信证券陈竹,王凯旋,韩世通0.811.091.552024-02-28
广发证券方程嫣,罗佳荣0.801.332.162024-02-25
中泰证券崔少煜,祝嘉琦0.801.101.532024-02-25
TOP↑